How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

What is the current share price of Recursion Pharmaceuticals (RXRX)? Recursion Pharmaceuticals's (RXRX) current share price is $3.31. This constitutes a price movement of 11.04% when compared to the ...

Kimi Antonelli needs a win in Belgium this weekend to pump up his Formula One championship lead after two blanks in the last three races, but Ferrari could stand in his way. Cricketcategory· July 14, ...

I know I’m old because I remember when a B+ was a respectable grade. Now it’s more like an indictment. I’m a masochist if I ...

Yahoo Sports TVyahoosports.tv is here! Watch live shows and highlights 24/7. The Kevin O'Connor ShowKevin O'Connor talks ball with the best names from around the world of basketball. The Ariel Helwani ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...